A prospective cohort study, conducted in Canada, to evaluate whether the use of the DCIS score changes the treatment recommended and the treatment received in women with low to moderate risk DCIS following breast conserving surgery who are candidates for radiation therapy. We plan to study 200 eligible, consenting women who will have their tumour tissue specimen sent to Genomic Health to assess their DCIS score.